Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.
How sex-dependent differences in molecular mechanisms could underpin men and women’s distinct experiences of chronic neuropathic pain.
How the RNA transcriptome of circulating neutrophils could hold the key to identifying intracranial aneurysms – before they rupture.
Progress in tissue engineering may offer hope to patients suffering from debilitating intervertebral disc degeneration.
Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions
Could resonance Raman spectroscopy be the key to your heart?
An analgesic is helping researchers explore new drug targets for sight-threatening diseases
Could an accidental discovery lead to a cure for sepsis?
New tests can speed up the diagnosis of severe sepsis, ensuring patients get the right treatment.
Diagnosis and prognosis of brain injury can be complex – but is simple blood test on the horizon?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
You will benefit from:
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal